Results
1 -
6 of
6
(Click
here to explore results)
- Drug Discovery for Psychiatric Disorders, CHAPTER 4 Glutamatergic Approaches for the Treatment of Schizophrenia. John A. Morrow, Robert Gilfillan, Stuart A. Neale
, 2012
, Pages 56-98
- Drug Discovery for Psychiatric Disorders, CHAPTER 5 Discovery and Clinical Data for a Novel AMPA Receptor Positive Modulator. Simon E. Ward
, 2012
, Pages 99-122
- Allosterism in Drug Discovery, CHAPTER 14 Development of AMPA Receptor Modulators as Cognition Enhancers. Craig Jamieson, Emma L. Duffy
, 2017
, Pages 310-333
- Drug Discovery for Schizophrenia, CHAPTER 6 Drugs that Target the Glutamate Synapse: Implications for the Glutamate Hypothesis of Schizophrenia. Catharine A. Mielnik, Amy J. Ramsey
, 2015
, Pages 115-140
- Drug Discovery for Schizophrenia, Subject Index
, 2015
, Pages 273-289
- Ion Channel Drug Discovery, CHAPTER 6 AMPA Receptor Positive Allosteric Modulators – a Case History. Simon E Ward
, 2015
, Pages 105-134